David H Henry
Overview
Explore the profile of David H Henry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
2047
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Henry D, Weycker D, Bensink M, Gawade P, Belani R
Int J Clin Pharm
. 2019 Apr;
41(3):619-620.
PMID: 30953273
No abstract available.
12.
Rubinstein P, Moore P, Rudek M, Henry D, Ramos J, Ratner L, et al.
AIDS
. 2017 Dec;
32(5):605-611.
PMID: 29280762
Objective: Brentuximab vedotin is a Food and Drug Administration approved anti-CD30 antibody drug conjugate potently active in Hodgkin lymphoma. Trials of brentuximab vedotin with doxorubicin, vinblastine, and dacarbazine (AVD-BV) excluded...
13.
Gawade P, Berlin J, Henry D, Tomita D, Brooks B, Franklin J, et al.
Pharmacoepidemiol Drug Saf
. 2017 Aug;
26(11):1357-1366.
PMID: 28809079
Purpose: Evaluate changes in use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in cancer patients receiving myelosuppressive chemotherapy following regulatory and reimbursement actions. Methods: Calendar year patient cohorts...
14.
Hosoya H, Levine J, Henry D, Goldberg S
Am J Med
. 2017 Mar;
130(6):e237-e240.
PMID: 28302386
No abstract available.
15.
Sparano J, Lee J, Palefsky J, Henry D, Wachsman W, Rajdev L, et al.
J Clin Oncol
. 2016 Dec;
35(7):727-733.
PMID: 27937092
Purpose Squamous cell carcinoma of the anal canal (SCCAC) is characterized by high locoregional failure (LRF) rates after definitive chemoradiation (CRT), associated with anogenital human papilloma virus, and often appears...
16.
Boccia R, Henry D, Belton L, Bohac C, Ghazal H
Cancer Med
. 2016 Nov;
5(12):3445-3453.
PMID: 27882724
Data on efficacy and safety of darbepoetin alfa (DA) administered at hemoglobin (Hb) ≤10 g/dL are limited. In this analysis, we examined DA's efficacy and safety in patients with Stage...
17.
Body J, Bone H, De Boer R, Stopeck A, Van Poznak C, Damiao R, et al.
Eur J Cancer
. 2015 Jun;
51(13):1812-21.
PMID: 26093811
Background: This analysis was performed to further characterise treatment-emergent hypocalcaemia in patients with bone metastases receiving denosumab. Methods: Laboratory abnormalities and adverse events of hypocalcaemia in patients with metastatic bone...
18.
Yang D, Chen W, Xiong J, Sherrod C, Henry D, Dittmer D
Proc Natl Acad Sci U S A
. 2014 Oct;
111(44):E4762-8.
PMID: 25341731
Primary effusion lymphoma (PEL) is an AIDS-defining cancer. All PELs carry Kaposi sarcoma-associated herpesvirus (KSHV). X chromosome-targeted sequencing of PEL identified 34 common missense mutations in 100% of cases. This...
19.
White C, Langholtz J, Burns Z, Kruse S, Sallee K, Henry D
Support Care Cancer
. 2014 Sep;
23(4):993-9.
PMID: 25256378
Purpose: Venous thromboembolism (VTE) is a known cause of morbidity in the oncology patient population. As hospital readmission rates are more frequently scrutinized, we sought to determine the most common...
20.
Hedenus M, Ludwig H, Henry D, Gasal E
Cancer Med
. 2014 Jun;
3(5):1416-29.
PMID: 24890561
Pharmacovigilance (PV) is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or other problems related to medical products after they have been licensed...